首页|不同硬化剂选择对体表软组织静脉畸形硬化治疗并发症的影响

不同硬化剂选择对体表软组织静脉畸形硬化治疗并发症的影响

扫码查看
目的 比较体表软组织静脉畸形硬化治疗中选择不同硬化剂的并发症发生率,探讨并发症预防措施以及观察与治疗要点.方法 回顾性分析自2011年1月至2023年12月,东部战区总医院烧伤整形科收治301例行硬化治疗、具有完整随访资料的体表软组织静脉畸形患者,按治疗硬化剂类型,分为无水乙醇组、泡沫硬化剂组、平阳霉素组和联合治疗组(无水乙醇+泡沫硬化剂),观察分析治疗相关并发症、处理措施和结果.结果 301例患者共完成636次治疗.无水乙醇组215例(454次);泡沫硬化剂组41例(80次);平阳霉素组12例(23次);联合治疗组33例(79次).并发症共358次(56.29%),包括:(1)疼痛、肿胀152次.(2)色素沉着17次.(3)浅静脉栓塞42次.(4)皮肤黏膜溃疡坏死25次.(5)肌肉/肌腱挛缩7次.(6)神经损伤引起麻木13次.(7)胃肠道反应1例.(8)因心理因素引起焦虑99次.无水乙醇组、泡沫硬化剂组、平阳霉素组、联合治疗组的并发症发生率分别为59.03%、62.50%、43.48%、37.97%.大部分并发症经保守治疗后恢复,仅3例需手术治疗.未出现过敏、异位栓塞、肝肾功能损伤、肺纤维化等全身严重并发症.结论 无水乙醇、泡沫硬化剂,以及平阳霉素的单独或联合硬化治疗均具有良好的有效性和安全性,但联合治疗并发症发生率更低.选择合适的硬化剂,精准定位,严格控制注射速度与剂量,及时有针对性地处理术后出现的异常反应,有助于并发症的预防及治疗.
Investigate the impact of different sclerosing agents on the complications in the sclerotherapy of cutaneous soft tissue venous malformations
Objective To analyze and compare the related complications after sclerotherapy of cutaneous soft tissue venous mal-formations by different sclerosing agents.And to explore preventive measures for complications,as well as key points in observation and treatment.Methods The cases with venous malformation in cutaneous soft tissue treated in our department from January 2011 to Decem-ber 2023 were reviewed.All patients had complete follow-up data.According to the type of sclerosing agents,they were divided into the anhydrous ethanol group,foam sclerosing agent group,Pingyangmycin group,and combined treatment group with anhydrous ethanol and foam sclerosing agents.The complications,treatment measures and results were analyzed.Results A total of 301 patients were included and 636 treatments were completed.In the anhydrous ethanol group,215 cases were treated with sclerotherapy 454 times.In the foam sclerosing agents group,41 cases were treated 80 times.Twelve cases in the pingyangmycin group were treated 23 times.In the combined treatment group,33 cases were treated 79 times.A total of 358 complications were observed,with an incidence of 56.29%,including.(1)Pain and swelling 152 times.(2)Pigmentation 17 times.(3)Superficial vein embolization 42 times.(4)Skin mucosa ulcer necrosis 25 times.(5)Muscle/tendon contracture 7 times.(6)Nerve injury caused numbness 13 times.(7)Gastrointestinal reaction:1 case.(8)Nin-ty-nine times of anxiety caused by psychological factors.Most of the complications recovered after conservative treatment,and only 3 cases required surgical treatment.The incidences of complications in the anhydrous ethanol group,foam sclerosing agents group,pingyangmycin group and combined treatment group were 59.03%、62.50%、43.48%and 37.97%respectively.There were no serious systemic complica-tions such as hypersensitivity,ectopic embolism,liver and kidney injury and pulmonary fibrosis.Conclusion Anhydrous ethanol,polydo-caol/lauryl alcohol foam and pingyangmycin alone or in combination with sclerotherapy have good efficacy and safety.The combined treat-ment has a lower complication rate.The selection of the appropriate sclerosing agent,precise positioning,strict control of injection speed and dosage,and timely handling of postoperative abnormal reactions can help in the prevention and treatment of complications.

Venous malformationSclerotherapyComplications

谢郝婷、余明薇、郑苗、王金金、袁斯明

展开 >

东部战区总医院 烧伤整形科,江苏 南京 210002

武汉市第三医院整形美容外科,湖北武汉 430000

静脉畸形 硬化治疗 并发症

2024

中国美容整形外科杂志
中国医师协会 辽宁省人民医院 沈阳军区总医院

中国美容整形外科杂志

CSTPCD
影响因子:0.605
ISSN:1673-7040
年,卷(期):2024.35(12)